Anmol N.

Anmol N. is a seasoned professional with a diverse background in neuroscience and business, currently serving as the CEO and Co-Founder of Nospharma, which aims to develop novel therapeutics for rare neurological disorders in collaboration with McGill University and District 3. In addition, Anmol N. holds multiple roles at District 3 Innovation, including Innovation and Strategy Associate, Start-Up Coach, Venture Associate, and Venture Fellow. Prior experience includes serving as a Clinical Specialist at the Centre universitaire de santé McGill, where significant contributions to rapid PCR testing during the COVID-19 pandemic were made. Anmol N. began an academic career at McGill University as a Research Scientist, leading projects that resulted in 13 publications, and gained valuable research experience as a Research Assistant at The Montreal Neurological Institute. Educational credentials include a Master of Science in Integrated Program in Neuroscience from McGill University, a Graduate Diploma in Business from the Smith School of Business at Queen's University, and a Bachelor of Arts and Science from McGill University.